Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: role of amino, fluoro, hydroxyl, methoxyl, methyl, methylene, and oxo substituents on affinity fo

doi:10.1021/jm701270n

Paper

Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: role of amino, fluoro, hydroxyl, methoxyl, methyl, methylene, and oxo substituents on affinity fo

Published Apr 5, 2008 · L. Hsin, Li-Te Chang, R. Rothman

Journal of medicinal chemistry

Q1 SJR score

9

Citations

0

Influential Citations

Open Access PDF Full text Semantic Scholar

Abstract

Novel derivatives of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909, 1) and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (GBR 12935, 2) with various substituents in positions C2 and C3 of the phenylpropyl side chain were synthesized and evaluated for their ability to bind to the dopamine transporter (DAT) and the serotonin transporter (SERT). In the C2 series, the substituent in the S-configuration, with a lone-pair of electrons, significantly enhanced the affinity for DAT, whereas the steric effect of the substituent was detrimental to DAT binding affinity. In the C3 series, neither the lone electron pair nor the steric effect of the substituent seemed to affect DAT binding affinity, while sp (2) hybridized substituents had a detrimental effect on affinity for DAT. In the series, the 2-fluoro-substituted (S)-10 had the highest DAT binding affinity and good DAT selectivity, while the 2-amino-substituted (R)-8 showed essentially the same affinity for DAT and SERT. The oxygenated 16 and 18 possessed the best selectivity for DAT.

In Vitro Study

Study Snapshot

Substituted 3-phenylpropyl analogs with lone-pair electrons enhance dopamine transporter affinity, while steric effects hinder it, with 2-fluoro-substituted (S)-10 showing the highest binding affinity and good selectivity.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: role of amino, fluoro, hydroxyl, methoxyl, methyl, methylene, and oxo substituents on affinity fo

Sign up to use Study Snapshot

References

Effects of Combined Dopamine and Serotonin Transporter Inhibitors on Cocaine Self-Administration in Rhesus Monkeys

Combined inhibition of DAT and SERT transporter inhibitors effectively reduces cocaine self-administration in rhesus monkeys, warranting further investigation for potential cocaine medications.

Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.

High-affinity monoamine transporter ligands can be synthesized with selectivity for dopamine, serotonin, and norepinephrine, potentially offering pharmacological tools to block multiple transporters simultaneously.

Synthesis, molecular modeling, and biological studies of novel piperidine-based analogues of cocaine: evidence of unfavorable interactions proximal to the 3alpha-position of the piperidine ring.

Adding a methylene group between the piperidine ring and polar group in the 3alpha-substituent significantly improves the activity of piperidine-based analogues of cocaine, potentially benefiting drug development for cocaine abuse and neurological disorders.

Perinatal cocaine exposure reduces myocardial norepinephrine transporter function in the neonatal rat.

Perinatal cocaine exposure impairs myocardial norepinephrine transporter function in neonatal rats, while not changing protein expression.

Synthesis and pharmacological evaluation of 3-(3,4-dichlorophenyl)-1-indanamine derivatives as nonselective ligands for biogenic amine transporters.

(-)-(1R,3S)-11 effectively blocks methamphetamine-induced neurotransmitter release by reducing dopamine, serotonin, and norepinephrine uptake, with potential for long-acting depot formulations.

Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.

Biaryl analogues of conformationally constrained tricyclic tropanes show potent and selective norepinephrine reuptake inhibitors, potentially aiding in understanding cocaine's reinforcing properties.

Further exploration of 1-[2-[Bis-(4-fluorophenyl)methoxy]ethyl]piperazine (GBR 12909): role of N-aromatic, N-heteroaromatic, and 3-oxygenated N-phenylpropyl substituents on affinity for the dopamine and serotonin transporter.

N-aromatic, N-heteroaromatic, and 3-oxygenated N-phenylpropyl derivatives of 1-[2-[Bis-(4-fluorophenyl)methoxy]ethyl]piperazine show high affinity for both dopamine and se

Synthesis and dopamine transporter affinity of chiral 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(2-hydroxypropyl)piperazines as potential cocaine abuse therapeutic agents.

Chiral 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(2-hydroxypropyl)piperazines show high affinity and selectivity for dopamine transporter, making them potential candidates for long-acting cocaine abuse therapeutic agents.

Therapeutic and adverse actions of serotonin transporter substrates.

New medications can be developed that selectively release serotonin without increasing the risk of adverse effects like valvular heart disease, primary pulmonary hypertension, and neurotoxicity.

Citations

Stereoelectronic basis for the kinetic resolution of N-heterocycles with chiral acylating reagents.

This study reveals a new stereoelectronic effect in amine acylation, enabling the kinetic resolution of various N-heterocycles using easily prepared reagents.

Ring-opening reactions of 1,4-diazabicyclo[2.2.2]octane (DABCO) derived quaternary ammonium salts with phenols and related nucleophiles.

DABCO-derived quaternary ammonium salts efficiently react with phenols and other nucleophiles to produce piperazines directly from primary alcohols, alkyl halides, or sulfonates in a one-pot method.

Molecular-biological problems of drug design and mechanism of drug action

Incazanum preparations [I] show complete biotransformation to chloroform in rats, while methanol extract shows less complete biotransformation.

Highly diastereoselective and general synthesis of primary β-fluoroamines.

This method allows for the highly diastereoselective synthesis of primary -fluoroamines with high yields, making it a promising strategy for synthesis of complex organic compounds.

Kinetic mechanism of dopamine transporter interaction with 1-(2-(bis-(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine (GBR 12909)

GBR12909 induces a "slow isomerization step" in dopamine transporters, a conformational change similar to PE2I, and is a general property of dopamine transporter proteins.

Dual DAT/sigma1 receptor ligands based on 3-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol.

Ester analogs of 3-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol) show high affinity and selectivity for DAT, with a maximum 16-fold D

Recent Advances and Challenges of the Drugs Acting on Monoamine Transporters.

Recent advances in human monoamine transporter inhibitors and structural studies promote structure-based drug design for novel, high-activity and selective compounds for treating depression and behavioral disorders.

Latest advancements on serotonin and dopamine transporters in lymphocytes.

Serotonin and dopamine transporters in lymphocytes may play a role in the immune system, with antidepressants potentially acting as substrates.